17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation

Leukemia

Volumn 23, Issue 3, 2009, Pages 625-627

  Dijkstra, M K ^a   van Lom, K ^a   Tielemans, D ^a   Elstrodt, F ^b   Langerak, A W ^a   van't Veer, M B ^a   Jongen Lavrencic, M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CHROMOSOME 17P; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA PROBE; DOWN REGULATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENETIC CODE; HUMAN; IMMUNOPHENOTYPING; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION;

EID: 62549148205     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.264     Document Type: Article

References (8)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804-815.
2. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910-1916.
3. Soussi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001; 1: 233-240.
4. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE et al p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007; 17: 1298-1307.
5. Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumer suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007; 26: 5017-5022.
6. van't Veer MB, Brooijmans AM, Langerak AW, Verhaaf B, Goudswaard CS, Graveland WJ et al. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 2006; 91: 56-63.
7. Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, van den Ouweland A et al. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res 2006; 66: 41-45.
8. Boonstra JG, van Lom K, Langerak AW, Graveland WJ, Valk PJ, Kraan J et al. CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): Comparison of three approaches to analyze its expression. Cytometry B Clin Cytom 2006; 70: 136-141.